Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BVTK Found a nice email in my in box this morning. I know it's yesterdays news, but I like seeing it. 8:04am
What's new at Bravatek for 07/01/2017
Updates from bravatek smart simple secure
In the 07/01/2017 edition
Bravatek Solutions Signs 3 Companies to Ecrypt One Pilot Programs - bravatek
http://bravatek.com/bravatek-solutions-signs-3-companies-ecrypt-one-pilot-programs/
Thanks bro. Exactly, what I've been trying to find.
Thanks again
I had my order in last night. I woke up to a small position. I like all the DD and optimism here today. I guess if there is a time for Bravatek, it would be now, and in the near future.
The SEWP contracts offer a vast selection and wide range of commercial advanced technology, including, desktops and servers, IT peripherals, network equipment, storage systems, security tools, software products, cloud based services, telecommunication, Health IT, video conferencing systems and other IT and Audio-Visual products along with product based services such as installation, maintenance and other services related to in-scope products to all Federal Agencies (including Department of Defense) and their approved support service contractors.
https://www.sewp.nasa.gov/geninfo.shtml
On April 17, 2017, Bravatek Solutions, Inc. (the “Company”) formally entered into a Reseller Agreement with i3 Integrative Creative Solutions, LLC (“i3 Integrative”), a Virginia-based service-disabled, veteran-owned small business ("SDVOSB"),etc...
http://www.i3ics.com/
https://sccefile.scc.virginia.gov/Business/S386640
In connection with the agreement, i3 Integrative secured approval for the Company to be listed as a supplier on the SEWP contract vehicle, usable by any federal agency, and because of i3 Integrative’s SDVOSB status, the Company can partner with i3 Integrative to obtain business set-aside contracts.
https://www.sec.gov/Archives/edgar/data/1449574/000147793217001806/bvtk_8k.htm
I was really hoping to see BVTK, or I3 ICS (i3 Integrative Creative Solutions) on the SEWP website. Anybody find them on there, yet?
https://www.sewp.nasa.gov/cgi/provider_lookup.pl
OR
https://www.sewp.nasa.gov/sewp5public/contractholders#/contractholderslist
https://www.sewp.nasa.gov/sewp5public/contractholders#/smallbusinesslist
I've been watching for a few days now. Looking to jump in here soon.
Good times ahead?
Short availability:
4/10 150K
4/11 100K
4/12 450K
https://www.interactivebrokers.com/en/index.php?key=ubqu&cntry=usa&tag=United+States&ib_entity=&ln=&asset=&f=4587&conf=am&amref=1
03/31/2017 -84,696 from 3/15 Short Interest Down %-78.57
http://otce.finra.org/ESI
ADVT I like the transparency, I like that they're producing and improving, I like the industry (room for growth, with unlimited potential), I like the Share structure, I like the management and team behind Advantis Corp. I even like the name. My likes out weigh my dislikes. Unusual for me here in this realm.
Colorado never ceases to amaze me in the MJ industry. I do see ADVT had very little cash on hand in "2015". "2016," sounds to me like they spent money, to make money. "2017" will reveal the true potential. From what I've been reading (thanks to the board) ADVT has a good name, good quality, and good service. Those can take a business far in my opinion. I'm an optimist, I see the glass as half full. With everything I've read here, i feel with creative financing, and good management this company can grow across the nation, in time. All in my opinion.
Thanks for the response Mightymoe
GLTA
KNDI some insider action today. Anybody listen to CC last week?
ADVT my first true MJ play. And I like it. I see potential all around. And I dig the SS, and Balance sheet seems to be improving little by little. Looking forward to 2016 10k, and 1st quarter 2017. I'm reading more and more alternative uses for MJ,and cannabis, almost daily. The numbers it can generate tax wise, are tremendous. I don't feel that's a good thing, but seems to be the argument anyone in politics likes to hear...how much anything can do for their personnel gain and the financial status of their state. I can picture it like that childhood story,"The Little Engine that Could."This industry is climbing a big hill right now. It will succeed in recognition to unlimited potential. Why stand in front of a steam engine gaining ground, and picking up speed. JMO. Thanks to you and all the folks here keeping us up-to-date. I don't post much, but read almost daily.
GLTA
ADVT IMO Any business in this industry that becomes legitamate and well established in any state, can grow and prosper generously everywhere in the future. ADVT has a nice system setup. The production value alone has tremendous potential. I'm looking forward to the future.
GLTA
ADVT Read this in the paper today.
Illinois lawmakers propose legalizing recreational marijuana
http://www.chicagotribune.com/news/local/breaking/ct-illinois-marijuana-legalization-proposal-met-20170322-story,amp.html
The numbers are amazing...
"Based on sales of recreational marijuana in Colorado, the Marijuana Policy Project, a national advocacy group, estimates sales in Illinois could generate about $350 million to $700 million per year."
ADVT Wow. The news here this morning sounds very interesting. The consolidation on the chart is much needed. IMO
GLTA
CCLX New to the board. I just read the news today. So far, I like the news. I'm all for cutting the cord.
https://www.otcmarkets.com/stock/CCLX/news
MATN SOUTH SAN FRANCISCO, Calif. – March 15, 2017 – Mateon Therapeutics, Inc. (OTCQX:MATN), a biopharmaceutical company developing vascular disrupting agents (VDAs) for the treatment of orphan oncology indications, today announced preliminary data from the third dose cohort of the ongoing Phase 1b study OX1222 in patients with relapsed/refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS). OX1222 is a dose-ranging Phase 1b study of OXi4503 combined with cytarabine. The third dose cohort enrolled four patients who received a dose of 6.25 mg/m2 of OXi4503 in combination with an intermediate dose (1g/m2/day x 5 days) of cytarabine.
https://www.sec.gov/Archives/edgar/data/908259/000119312517082743/d350105dex991.htm
PMCB JoeDaddy best I can do.I lost interest for a short time. Nice volume today.
6-Mar 193/549,582/766,025/101,180/1,416,787/$150,270
7-Mar 253/964,052/1,610,517/57,534/2,632,103/$278,160
8-Mar 175/654,389/1,002,751/156,902/1,814,042/ ?
9-Mar 213/1,393,411/1,083,305/36,267/2,512,983/$267,740
10-Mar ? / ? / ? / ? /1,116,862/ ?
Week: 10 834 / 3,561,434 / 4,462,598 / 351,883 / 9,492,777 / $
Missed Friday 3/10
13-Mar 209/787,665/1,165,061/116,799/2,069,525/$210,670
14-Mar 291/2,327,512/1,884,776/117,888/4,330,176/$433,810
GLTA
Thanks Pistol Pete. I guess I could've asked. Until tomorrow, my friend.
Go PMCB
Some changes were made to Pharmacyte Biotech Europe Limited.
That's a dead end for me. I tried to Google what some of them were but came back with nothing. Not interested enough to pay for it. I'm here for the long run..Go PMCB
http://www.vision-net.ie/Company-Info/Pharmacyte-Biotech-Europe-Limited-548776#summary
I did entity searching for Austrianova in each country. Coundn't find Austrianova Vienna. Only Bavarian Nordic GmbH is a wholly-owned subsidiary of the Danish Bavarian Nordic A / S, Kvistgård, Denmark - Bavarian Nordic A / S.
Martinsried, 19 May 2016
*Must search for Bavarian Nordic* & Google translate if interested.
https://www.unternehmensregister.de/ureg/result.html;jsessionid=C7D93E885238DD180582EF2DFADBA6A3.web04-1?submitaction=showDocument&id=18597123
AUSTRIANOVA SINGAPORE PTE. LTD. *Austrianova works for search*
https://www.tis.bizfile.gov.sg/ngbtisinternet/faces/oracle/webcenter/portalapp/pages/TransactionMain.jspx?selectedETransId=dirSearch#%40%3FselectedETransId%3DdirSearch%26_adf.ctrl-state%3D6216sw9z3_9
AUSTRIANOVA (THAILAND) COMPANY LIMITED
Search bar top right*Austrianova search* Must choose (begins with)
http://www.dbd.go.th/Applications/cds/
I'm sure everyone here knew this, but I was bored tonight.
GLTA
I'll agree. I'm not to familiar. I do see you on here all the time. I was reading an article from Austrianova website.
Some of the major players in global GMP cell banking service market include Virusure, Syngene, Sigma-Aldrich Co. LLC., WuXi AppTec, Zelle Biotechnology Private Limited, Microbiology Quality & Associates, Charles River Laboratories International, Inc., IHC World, LLC., Paragon Bioservices, Inc., Austrianova, VertMarkets, Inc. and others.
http://www.medgadget.com/2017/02/gmp-cell-banking-service-market-to-reflect-impressive-growth-rate-during-2016-2024-persistence-market-research.html
http://austrianova.com/
GL
Well, not sure this is relevant, but I remember reading this in the last 10q:
In July 2016, the Company entered into a Binding Memorandum of Understanding with Austrianova (“Austrianova MOU”). Pursuant to the Austrianova MOU, Austrianova will actively work to seek an investment partner or partners who will finance clinical trials and further develop products for the therapies for cancer, in exchange for which we, Austrianova and any future investment partner or partners will each receive a share of the net revenue of applicable products in designated territories.
https://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=11719599
I was over on Austrianova website. Looking good over there. They claim to be attending some Expo's (1)March 22, and rest later this year.
http://austrianova.com/
GLTA
Saw this on another board. I'm sure everyone here is aware, but thought I would post anyway;
The U.S. Drug Enforcement Administration will reclassify marijuana as a “Schedule Three” drug on March 15, 2017, essentially legalizing medicinal cannabis in all 50 states with a doctor’s prescription, said a DEA lawyer with knowledge of the matter.
http://longlivehealthtip.online/a-big-news-trump-administration-will-legalize-marijuana-and-cannabis-on-march-15-2017/
I'm anxious to see how this turns out.
Agreed. The Truck It App has great potential. I can't compare costs, but I'm a big fan of the Taco Bus in Tampa Bay area. Always looking for them on all events I attend. Honestly, I've never thought of installing an app until now. I actually just google searched for an app similar. Interesting.
GLTA
http://www.thetruckitapp.com/
That's amazing. I live in the wrong state. Thanks for the response.
Jumped aboard the other day. Beautiful photos on ADVT Facebook page. AJ Gentile, CEO Speedweed is a speaker at the expo this weekend.
http://www.calcanbizexpo.com/speakers/
http://www.calcanbizexpo.com/speaker/aj-gentile/
Wish I could attend. Anyone know what one of those cans cost?
Great board. Glad to be here.
PMCB The 4 year weekly, and daily reveal significance here in this .10 range. Not much for holding long term, but I'm impressed with," company focused on developing therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®." I will not lie, I'm here to trade (the company needs cash, and so do I). I will take advantage of opportunity, however, I'm more hopeful for those this technology can help. I'm no doctor or chemist, but I do like what I hear about Ciab.
GL
PMCB Back in on the 8th @.10 and some change. Turning out to be strong support there. I'm going to stick around for awhile. Thanks Pistol Pete for the updates and confidence.
GLTA
PVCT: Can anyone share their experiences with: "proposed sale to the public:"
https://www.sec.gov/Archives/edgar/data/315545/000119312517013156/d274304ds1a.htm
PVCT: I will stand behind your opinion if you can provide me some medical material that debunks ph-10, and pv-10. There is a conference in the near future Provectus Biopharmaceuticals was invited to:
http://www.provectusbio.com/news/press-releases/provectus-pr-20161222-1
I personally can not tell you much about Chemistry/Pharmaceuticals, but I will state....something has to happen here. Please tell me more. I am interested. However, I'm not interested in BOD, investor confidence, or litigation. Because (IMO)they all suck right now. Obviously, as Zorro mentioned....SP has not fallen into sub-level. I'm not sure why....Bombay has been here for a while. I have been here for 3 weeks. Welcome to the party. Please tell me more. No disrespect. Thank you in advance.
GLTU/All In fact....Trade Well/Trade Smart
PVCT:"Sell asap! Don't hold. Scam." Thank you Sillywillie, I will do just that. I see Nothing here. Thanks...for your opinion, and information to support your opinion. GLTU/ALL
"Net across all investments, next week should bare developments towards proper valuation. Hold onto your shares and ride the lightning north"
Lol...I'm going for it. I read through to page 28. I quit.
Assuming that all 19,945,132 Units are sold in the Rights Offering (which number is an estimated maximum amount of Units, calculated by using the number of shares of common stock and Listed Warrants outstanding as of December 30, 2016 and including in such amount the number of shares of common stock issuable upon conversion of the remaining outstanding shares of Series B Preferred Stock as of December 30, 2016), after deducting fees and expenses payable to the dealer-manager, and after deducting other expenses payable by us, we estimate the net proceeds of the Rights Offering will be approximately $ million. We intend to use approximately $15.6 million of the net proceeds from the exercise of Subscription Rights for clinical development, consisting of: approximately $9.3 million to expand the geographic scope necessary to complete patient accrual in our ongoing phase 3 clinical trial of PV-10 to treat locally advanced cutaneous melanoma; approximately $3.6 million to complete patient accrual in the phase 1b portion and begin the phase 2 portion of our phase 1b/2 combination study of PV-10 and Merck’s
KEYTRUDA in late stage melanoma; approximately $1.2 million to conduct our phase 1b/2 study of PV-10 in liver cancer (hepatocellular carcinoma); and approximately $1.5 million to conduct exploratory pre-clinical studies and phase 1 clinical studies to support current and future oncology indications. We intend to use any remaining net proceeds for working capital and general corporate purposes. See “Use of Proceeds.”
p.22
Page 28 & 29 Contain info about Culpepper and Dees
https://www.sec.gov/Archives/edgar/data/315545/000119312517013156/d274304ds1a.htm
GLTA
PVCT Well, I would like to hear something. It's been to long. I was looking at the calender on Provectus Website.
February is a busy month in the industry.
http://www.provectusbio.com/calendar-of-events/2/2017
According to the PR released on 12/22/2016; (2 events)
Clinical Interventional Oncology (CIO) on February 4-5, 2017
Asian Pacific Association for the Study of the Liver (APASL) on February 15-19, 2017
KNOXVILLE, Tenn.--(BUSINESS WIRE)--Provectus Biopharmaceuticals, Inc. (OTCQB:PVCT, www.provectusbio.com), a clinical-stage oncology and dermatology biopharmaceutical company ("Provectus" or "The Company"), today announced acceptance of two abstracts for poster presentations at international oncology conferences in February 2017. Both abstracts describe data from the Company's phase 1 study of PV-10 in tumors of the liver (https://www.clinicaltrials.gov/ct2/show/NCT00986661).
http://www.provectusbio.com/news/press-releases
I haven't searched any of the events to see if I could find who is presenting, or if a schedule is even provided. I'm really not interested. Just looking for an update.
I hope this situation between BOD, and Execs does not interfere. Time to GROW UP Provectus Bio pharmaceuticals Inc...geeze. The Ph.D on the end of their names should mean something.
GLTA
PMCB Thanks for posting. I can understand this article. I'm not sure why this has taken so long to surface here in the U.S. I have someone very close to me who just started stem cell treatment in Florida. Why do these practices take so long to reach the U.S???
GLTA
PMCB Looking forward to re-entry. I remain optimistic. I like the candle pattern today. Although,price up on light volume??? Hope to hear good news. Level 3 montage from last week shows seller pressure all week. Looking for anything positive this week. GLTA
1/2/2017M- Closed- Closed- Closed- Closed
1/3/2017T- 1,061,695- 2,414,497- 195,838- 3,672,030- $536,810
1/4/2017W- 2,795,934- 3,647,638- 251,868- 6,695,440- $935,000
1/5/2017TH- 1,692,125- 3,771,496- 157,537- 5,621,158- $745,760
1/6/2017F- 5,082,351- 8,196,026- 616,827- 13,895,204- $1,630,000
Week: 1-- 10,632,105-- 18,029,657-- 1,222,070-- 29,883,832-- $3,847,570
1/9/2017M- 1,855,137- 1,716,732- 59,859- 3,831,728- $456,660
https://www.sec.gov/cgi-bin/browse-edgar?company=PharmaCyte+Biotech%2C&owner=exclude&action=getcompany
GLTA
PVCT Quiet today??? Whats happening? Anyone,spoke to someone? Any more litigations abroad? I'm almost ashamed to call myself a shareholder. I hope the market doesn't feel this way. Something needs to happen here.
BERI I found an email from 01/08, interesting. I don't recollect the ticker, but website looks familiar...way back when.
http://web.archive.org/web/*/http://blueearthresources.com
OK, I have been studying and playing the stock market for many years. I have never taken much interest in pharmaceuticals, I have my reasons. PVCT came to me in a scan I ran a few weeks ago. In reading the PR released this morning, I discovered something I will continue to support and invest what I can in furthering the R&D in hopes of successfully moving forward in the fight against cancers of all, for all. I'll admit to shedding a tear almost every time I view any commercial asking for donation for children battling this disease. I have not seen many clinical trials with a focus for our children.
"Like many companies in our industry, our development efforts have historically focused on adult cancers,"
"We are pleased to collaborate with Provectus on this shared vision to advance promising new approaches for cancer that ultimately could lead to new treatments for pediatric patients, leveraging PV-10's novel characteristics and mechanism of action," said Dr. Trippett.
I would sincerely enjoy seeing Provectus with their PV-10 successful.
This is just my opinion, and my emotion, certainly not my technical stand point.
GLTA
https://www.pvct.com/pressrelease.html?article=20161208.1
Jumped in a little to soon myself. I just received an email with a link to:
Provectus presented at the 9th annual LD Micro Main Event on December 6, 2016 in Los Angeles. Tried to listen with my phone but I lost it twice. I had to start over each time.
http://www.provectusbio.com/news/in-the-media/provectus-news-20161207-1
PV-10 pipeline has been in play for a while now. Amazing not much has happened here. Why no positive results? This company should be trading much higher if PV-10 had any value, in my opinion. Appears the trust and confidence has been lost. It'd be nice to see them succeed, great cause here. I would love to invest more but looking for something positive. What is it, 180 days to comply with Nasdaq listing requirements?
GLTA
Big dump, so far, today. Took a small position here early in the week. I was looking for the bounce, but today is a tough sit through. Almost ready to bail. Thanks to all for the insight.
GLTA